Sugarsquare. Focus on the Adolescent: Digital Treatment of Type 1 Diabetes Through the Internet
1 other identifier
interventional
65
1 country
1
Brief Summary
Background The treatment of diabetes is multidisciplinary. Alignment of care of the various professional disciplines is, however, not always optimal. This can lead to confusion about treatment interventions and behavioral advices. In adolescence, good fine-tuned care is of extreme importance because of the difficulties in regulation of the disease in this phase of life (Snoek, 2004). These difficulties are due to biological changes but also to socio-psychological developmental changes. The adolescents' psychological development demands more autonomy and responsibility for the diabetes (care) by the adolescent. The social development can conflict with the treatment regime, because of the adolescents' social needs (ADA, 2001; Houdijk, 1998; Snoek, 2004). In this study the investigators assess whether an interactive website, on which adolescents with diabetes and their treatment team can communicate, leads to better alignment of care and better control over the disease. Intervention The diabetes has great impact on the adolescents' everyday life. Finding a balance between more autonomy, participating in social life with (healthy) peers and control of the disease is difficult and seems to act as a thread during this phase in life. This can lead to questions and uncertainty at any given moment. The interactive website provides the adolescent access to information and to his or her individual treatment plan and advices fitted to his or her condition and life. The adolescent can pose questions at any given moment through the online forum and their personal treatment page. Since the treatment team answers the question within a day, fit between diabetes care and adolescents' everyday life is optimized. Research question Does an online interactive treatment environment, on which adolescents with diabetes can communicate with their treatment team, lead to better fit of care and to better disease control?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
November 22, 2010
CompletedFirst Posted
Study publicly available on registry
November 30, 2010
CompletedNovember 30, 2010
November 1, 2010
1.2 years
November 22, 2010
November 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients' Evaluation of Quality of Care
Participants' appreciation of our diabetes care was assessed using the Patients' Evaluation of Quality of Diabetes care (PEQ-D; Pouwer \& Snoek, 2002). This questionnaire consists of 14 items, such as: 'The amount of information I receive from the doctor is…'. The adolescent is asked to answer by means of a 5-point lykert scale varying from 1) bad to 5) excellent.
T0: baseline (1 month prior to acces to intervention); T1: (6 months following T0); T2: (12 months following T0).
Secondary Outcomes (5)
Health Related Quality of Life
T0: baseline (1 month prior to acces to intervention); T1: (6 months following T0); T2: (12 months following T0).
Adolescents' disease knowledge
T0: baseline (1 month prior to acces to intervention); T1: (6 months following T0); T2: (12 months following T0).
Confidence In Diabetes Selfcare
T0: baseline (1 month prior to acces to intervention); T1: (6 months following T0); T2: (12 months following T0).
Glycemic control (HbA1c)
T0: baseline (1 month prior to acces to intervention); T1: (6 months following T0); T2: (12 months following T0).
Degree of use of intervention
T1 (6 months following start of intervention)
Interventions
Our intervention, Sugarsquare, is a secured treatment environment only accessible by patients of the KDCN and members of the treatment team. Sugarsquare consists of two main sections. The first section is a semi-public setting on which adolescents can exchange experiences with their diabetes (care) through a forum and a real time chat-application. All patients and treatment team members can see all messages posted here. The second section consists of patients' individual pages with treatment overview and an application for private interaction with the treatment team. Patients can only access their own individual page; treatment team members can access pages of all patients. Sugarsquare is a secured webpage, accessible only through computers equipped with the right certificate (access device) and by using the appointed username-password combination.
Eligibility Criteria
You may qualify if:
- adolescents aged 12 and older;
- diagnosed with diabetes mellitus;
- receiving regular outpatient hospital-delivered diabetes care provided by the Children's Diabetes Center Nijmegen (CDCN)
You may not qualify if:
- adolescents who were unable to read questionnaires because of language, or cognitive problems were excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Diabetes Center Nijmegen
Nijmegen, Gelderland, Postbus 9015; 6500 GS, Netherlands
Related Publications (1)
Boogerd EA, Noordam C, Kremer JA, Prins JB, Verhaak CM. Teaming up: feasibility of an online treatment environment for adolescents with type 1 diabetes. Pediatr Diabetes. 2014 Aug;15(5):394-402. doi: 10.1111/pedi.12103. Epub 2013 Dec 18.
PMID: 24350732DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emiel Boogerd, MSc.
Radboud University Nijmegen, Medical Center
- PRINCIPAL INVESTIGATOR
Chris Verhaak, Dr.
Radboud University Nijmegen, Medical Center
- PRINCIPAL INVESTIGATOR
Kees Noordam, Dr.
Radboud University Nijmegen, Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 22, 2010
First Posted
November 30, 2010
Study Start
February 1, 2009
Primary Completion
April 1, 2010
Study Completion
November 1, 2010
Last Updated
November 30, 2010
Record last verified: 2010-11